クレーン・カンパニー（CR）2026年第3四半期決算説明会：過去最高の利益率を背景にEPSガイダンスを上方修正

クレーン（CR）は2026年度第3四半期の決算説明会において、航空・防衛需要、プロセス・フロー・テクノロジーズ部門の受注改善、計画を上回る買収業績に支えられ、広範な成長を記録したと発表した。経営陣は通期の調整後EPS予想を引き上げ、為替影響を除くコア受注残高が9%増加したことを強調した。

主な要点

• 売上高合計は前年同期比28%増加し、これには8%のコア成長と4件の買収による21%の寄与が含まれる。
• 調整後営業利益は36%増加し、買収による一時的な希薄化にもかかわらず、調整後営業利益率は130ベースポイント拡大して過去最高の22.5%となった。
• 為替影響を除くコア受注残高は前年同期比9%増加した。プロセス・フロー・テクノロジーズ部門の受注が20%増加したことが牽引し、コア受注は11%増加した。
• 経営陣は2026年度通期の調整後EPS予想の中央値を0.35ドル引き上げ、7.23ドル〜7.38ドルとした。
• エアロスペース & アドバンスト・テクノロジーズ部門の売上高は前年同期比27%増の3億4,400万ドルとなり、コア売上高は9.5%増、調整後セグメント利益率は26.3%に達した。
• プロセス・フロー・テクノロジーズ部門の売上高は29%増の4億1,300万ドルとなった。コア売上高は6.2%増加し、調整後セグメント利益率は過去最高の24%に達した。

主要財務データ

同社は、本業の営業動向から分けるため、一時的な関税還付（回収）による恩恵を調整後業績から除外した。

事業および業績動向

エアロスペース & アドバンスト・テクノロジーズ

エアロスペース & アドバンスト・テクノロジーズ部門の売上高は前年同期比27%増の3億4,400万ドルとなり、コア売上高は9.5%増加した。

同セグメントの受注残高は13億ドル近くに達し、コアベースで9%、買収の影響を含めると20%増加した。成長は民間向け新機（OE）生産の拡大と幅広い防衛需要に支えられた。前年の初期部品補給（イニシャル・プロビジョニング）の影響を除くと、アフターマーケット売上高合計は11%増加し、コア民間アフターマーケットは1桁台後半のペースで増加した。

調整後セグメント利益率は100ベースポイント上昇し26.3%に達した。経営陣は、新機（OE）売上比率の増加や予想通りの買収による希薄化があったにもかかわらず、この成果を達成したと述べた。

防衛分野における機会は、ミサイル防衛、レーダー、高度電力変換、宇宙機能に引き続き集中している。クレーンは約15のミサイルプログラムに参加しており、2026年の収益基盤は約3,500万ドルとなっている。経営陣は、この事業活動が2027年に40%〜50%成長すると見込んでおり、その需要の多くはすでに受注残高に含まれている。同社はまた、本事業が2020年代の残り期間で現在の4倍から6倍の規模に拡大する可能性があると見込んでいる。

プロセス・フロー・テクノロジーズ

プロセス・フロー・テクノロジーズ部門の売上高は29%増の4億1,300万ドルとなった。コア売上高は6.2%増加し、買収が成長に約24パーセンテージ・ポイント寄与した。

為替影響を除くコア受注残高は前年同期比8%増、前四半期比2%増となった。受注は前年同期比20%増、前四半期比8%増となった。調整後セグメント利益率は80ベースポイント上昇し、過去最高の24%となった。

超低温（クライオジェニクス）、電力、上下水道、医薬品、原子力、一般産業市場全般で需要が改善した。超低温分野は宇宙ロケット打ち上げインフラや航空宇宙環境試験の好調の恩恵を受けた。電力需要は米国の天然ガスコンバインドサイクル発電タービンへの投資が牽引し、医薬品分野の動きは米国の能力拡張やリショアリング（国内回帰）関連プロジェクトを反映した。

化学分野の需要は横ばいで推移した。経営陣は、プロセス・フロー・テクノロジーズ部門が化学分野の回復に依存しにくくなったことを強調し、化学分野への暴露（ポートフォリオ比率）が過去の約30%から約20%に低下したと述べた。ポートフォリオに占める割合は、上下水道が約15%、一般産業が約20%、ガスおよび原子力発電の合計が約15%となっている。

地域別では、経営陣は米国を最も堅調な市場、欧州を概ね横ばい、中東を上半期の軟調さから回復しつつある市場と説明した。

ポートフォリオと買収

最近の買収案件は、売上高、利益率、利益の面でクレーンの当初予想を上回り続けている。経営陣は現在、これらの買収が2026年の調整後利益に1株当たり約0.30ドル貢献すると見込んでおり、前回の予想である0.20ドルから引き上げた。これらの営業利益率は2026年に500ベースポイント以上拡大する見込みである。

クレーンはまた、10%の投下資本利益率（ROIC）ハードル率を当初計画より約18か月早く達成すると見込んでいる。

予定されているトリリウム（Trillium）のポンプ事業の買収は、上下水道分野におけるクレーンのポジションを強化することを目的としている。ビルディング・サービス & ユーティリティーズ事業の売却計画により、同社の非住宅建設分野への事業展開からの撤退が完了する。経営陣は、ポートフォリオの見直しを毎年行っているものの、現時点で追加の大規模な事業売却は検討していないと述べた。

業績予想

経営陣は、クレーンが両事業セグメントにおいて過去最高の受注残高と勢いをもって2027年を迎えると予想している。同社は、ニューヨーク市で2月9日に開催予定のインベスター・デイで、戦略、成長機会、長期見通しの詳細を発表する予定である。

リスクおよび注目事項

• 直近の買収案件は、実績や利益率の改善が計画を上回っているものの、報告上の利益率に対しては一時的に希薄化要因となっている。
• 化学市場は引き続き横ばいである。経営陣は、少なくとも2027年上半期までは建設や耐久財が牽引する本格的な回復は見込んでいない。
• 欧州は2027年にかけて横ばいが続くと予想される一方、米国および中東の化学市場はより良好なプロジェクト活動を提供している。
• トリリウムの利益率はクレーンの全社利益率を下回っており、ビルディング・サービス & ユーティリティーズ事業の売却により年間売上高予想が約1億6,000万ドルの事業が除外されることになる。経営陣は、取引のタイミング次第ではあるが、トリリウムがそれに伴う影響の大部分を相殺すると見込んでいる。
• 中東市場への暴露（依存度）は全社全体の5%未満である。以前の出荷遅延は概ね正常化したが、運賃コストは引き続き高水準にある。

アナリストQ&Aの要約

経営陣は、主要な買収事業からの上振れ余地が当初の予想以上に拡大していると述べた。EBITDAを6,000万ドルから1億5,000万ドルに拡大するという前回の5か年目標は前倒しで達成される見込みであり、経営陣は5年目の時点におけるさらなる高成長と利益率向上も見込んでいる。

資本配分について、クレーンは買収案件をクレーン・ビジネス・システムを通じて評価していると述べた。同社は、3〜5年の期間でポートフォリオを強化し株主価値を創造できるものであれば、運用改善の機会がある資産と、すでに良好に運営されている高成長資産の両方を引き続き検討対象としている。

プロセス・フロー・テクノロジーズ部門の利益率に関して、経営陣は好調な限界利益率の要因として、価格設定、生産性向上、高成長・高利益率事業へのミックスシフトを挙げた。当四半期のコア営業レバレッジは40%をわずかに上回り、経営陣はサイクル全体を通じた35%〜40%のレバレッジ・フレームワークを改めて強調した。

経営陣は、ビルディング・サービス & ユーティリティーズ事業の売却とトリリウムの買収が第1四半期末頃に完了すると見込んでいる。どちらの取引も通期全体に影響を与えるわけではないため、クレーンはトリリウムが年度内の事業売却による利益希薄化の大部分を相殺すると見込んでいる。

決算説明会文字起こし全文

決算説明会の完全なトランスクリプト

経営陣による説明

Operator

Welcome to the Crane Company Third Quarter 2026 Earnings Conference Call. [Operator Instructions] I'd like to now turn the call over to Allison Poliniak, Vice President of Investor Relations. Please go ahead.

Allison Ann Poliniak-Cusic

Thank you, Stephanie, and good day, everyone. Welcome to our third quarter 2026 Earnings Release Conference Call. I'm Allison Poliniak, Vice President of Investor Relations. On our call this morning, we have Alex Alcala, President and Chief Executive Officer; and Rich Maue, our Executive Vice President and Chief Financial Officer; along with Jason Feldman, Senior Vice President, Treasury and Tax who's on for Q&A.

We will start up our call with a few prepared remarks, Alex and Rich, after which we will respond to questions. And just a reminder, the comments we make on this call will include some forward-looking statements. We refer you to the cautionary language at the bottom of our earnings release and also in our annual report, 10-K and subsequent filings pertaining to forward-looking statements.

Also during the call, we will be using some non-GAAP numbers, which are reconciled to the comparable GAAP numbers and tables at the end of our press release and accompanying slide presentation, both of which are available on our website at craneco.com in the Investor Relations section. Now let me turn the call over to Alex.

Alejandro Alcala

Thank you, Allison, and good morning, everyone. Crane delivered another quarter of record performance, reflecting the strength of our portfolio, broad-based demand across our end markets, exceptional execution throughout the company and the continued success of our acquisition strategy.

Demand remains very strong across Aerospace and Advanced Technologies Momentum continues to build within process for technologies, and our recent acquisitions are performing well ahead of expectations. Together, these drivers resulted in an 8% core sales growth. Strong operating leverage, record margins, record earnings and a record backlog while reinforcing our confidence in the outlook for both 2026 and 2027.

Of note, order activity was particularly strong in process both technologies, where core orders increased 20% year-over-year and 8% sequentially. This combined with exceptional strength and resilience across the aerospace and Advanced Technologies, total company backlog increased 9% year-over-year providing strong visibility as we close out the year and enter 2027.

Execution continues to be a key differentiator, adjusted operating margin expanded 130 basis points to a record 22.5% despite the temporary dilutive impact of our recent acquisitions. These results demonstrate our ability to translate growth into meaningful earnings expansion while continuing to invest for the future.

Our acquisitions continue to significantly exceed expectations. Revenue growth, margin expansion and earnings contribution are all ahead of plan. And we now expect to achieve our 10% ROIC hurdle approximately 18 months earlier than originally anticipated. We expect these acquisitions to contribute approximately $0.30 per share to 2026 earnings up from our previous expectation of $0.20 per share, with operating margins expanding more than 500 basis points this year.

These incredible results reinforce our confidence in the Crane business system and our ability to create substantial shareholder value through disciplined capital deployment. We are equally excited about the opportunities ahead including the pending acquisition of [ Trillium ] pumps. Given our strong year-to-date performance, record backlog levels and confidence in both our core and acquired businesses, we are raising our full year adjusted EPS outlook by $0.35 at the midpoint to a range of $7.23 to $7.38 per share.

Turning to Aerospace & Advanced Technologies. This segment continues to perform exceptionally well. Demand remains robust across commercial aerospace, defense and space, supported by a record backlog and a growing pipeline of opportunities. Commercial aerospace remains healthy with solid OE demand and continued strength in aftermarket.

On the defense side, investment remained very strong as customers continue to prioritize missile defense, radar, advanced power inversion and space-based capabilities. All areas where we continue to invest and win. Strong execution and continued program wins are providing increasing visibility into the future growth.

As a result, we continue to expect 2026 core growth modestly above the high end of our long-term 7% to 9% growth framework, leveraging that growth between 35% and 40%. The team continues to execute at a very high level, and we remain highly confident in the long-term growth opportunities across the segment.

Process [indiscernible] Technologies also delivered an outstanding quarter. The business returned to core growth while delivering record profitability. Core sales increased 6%. Orders grew 20%, and adjusted operating margins expanded despite the dilutive impact of recent acquisitions. More importantly, the transformation of the portfolio continues to gain momentum.

Growth was broad-based across cryogenics power, wastewater nuclear and general industrial markets. We secured additional wins in cryogenics, supporting the growing space launch market. New pharmaceutical orders related to GEO P1 capacity expansion and further wins in wastewater and power.

For the full year, our outlook has improved. Driven by solid core growth in the second half. We now expect low single-digit core growth full year and continued margin expansion. We also continue to enhance the quality of our portfolio through disciplined capital allocation.

The announced acquisition of Trillium pumps strengthens our position in the attractive water and wastewater market. while the announced divestiture of our Building Services & Utilities business further sharpen the strategic focus of the segment. Before moving on, I want to recognize and thank the outstanding Basin team.

For nearly 120 years, this business has been an important part of Crane, built by incredibly talented people who consistently deliver results the right way. We are grateful for the many contributions and proud of what they have accomplished. As they begin this next chapter, I'm confident they have a bright future ahead.

Together, these actions continue to reposition PFT around highly engineered mission-critical technologies, serving attractive growth markets, including pharmaceuticals, water and wastewater, power Progenics and nuclear. Importantly, we are not finished. We continue to see attractive opportunities to further strengthen the portfolio and remain confident in our ability to outperform the markets we serve over the long term.

To summarize, Crane is performing at a very high level. Our businesses are executing exceptionally well. Our end markets remain attractive. Our acquisitions are exceeding expectations. Our portfolio continues to become stronger and more resilient.

We will enter 2027 with record backlog, strong momentum across both segments increasing earnings power and significant strategic flexibility. As we look toward 2027, our confidence continues to grow. Over the summer, we completed strategy reviews across all our businesses, and those we reinforce our long-term growth framework.

In particular, 4 themes stand out. First, Aerospace and Advanced Technologies remains exceptionally well positioned. Strong aerospace and defense demand, combined with the benefits of years of investment in differentiated technologies, creating a resilient portfolio gives us confidence in the segment's ability to deliver attractive growth for many years to come.

Second, the transformation of the process flow technologies portfolio is gaining momentum. While the benefits are increasingly visible in our results today, we believe we are still in the early innings of our value creation journey as we continue to reshape the portfolio around higher growth, higher margin and less cyclical markets.

Third, our acquisition strategy continues to create meaningful value. We have significant capacity to deploy capital, a robust pipeline of opportunities and a proven ability to integrate businesses and accelerate earnings, margins and returns.

And last, but most important, we have an incredible intangible asset, the Crane Business System. The combination of world-class processes and a high-performance culture built on focus, intensity and accountability, continues to differentiate Crane and drive sustainable value creation.

pimply put, our businesses are performing very well. Our portfolio is stronger, it has ever been, and we continue to see significant opportunities to create value through both organic and inorganic growth.

Before turning it over to Rich, I'm pleased to announce that we will host our next Investor Day on February 9 in New York City. We look forward to sharing more about our strategy, growth opportunities and long-term outlook at that event.

With that, I'll turn the call over to Rich.

Richard Maue

Thank you, Alex. Another outstanding quarter with certainly more to come. Alex, as you just said, the Crane business system, this machine that we have and this unique culture is what enables us to consistently deliver the results that we do quarter after quarter. .

And it reminded me of the Academy Award-winning movie Fletch during an iconic scene, where Chevy Chase was impersonating Gordon Liddy, an airplane mechanic supervisor. During that scene, I was reflecting on our well oiled machines and I thought about full or coaching to our leadership teams and even how we talk with our investors when Fletch pro claims, it's so simple maybe you need to refresh your course.

It's all ball bearings nowadays guys. Now you just prepare that [indiscernible] valve with that 3 in 1 oil and some gas pads and I'm going to need about 10 courts of any freeze preferably prior. No, no make that Quaker Stan, and we'll just keep delivering top quartile results quarter after quarter.

And with that in mind, let me start off with total company results. Total sales were up 28% in the quarter compared to last year with 8% core growth, reflecting broad-based strength across both process flow technologies and aerospace and advanced technologies. Sales from our 4 acquisitions contributed 21% growth in the quarter, once again outperforming our expectations.

Adjusted operating profit increased 36%, reflecting the impact of the higher core sales contributions from the acquisitions, productivity and favorable pricing net of inflation, another outstanding result. And total core FX neutral backlog was up 9% compared to the prior year, reflecting strength at both Aerospace and Advanced Technologies and Process flow technologies.

Core orders increased 11% year-over-year, with continued strength in Aerospace & Advanced Technologies, up 2% as expected. And when excluding a multiyear order received in the same period last year, we're up in the mid-teens and process flow technologies up an exceptional 20%.

We generated strong free cash flow in the quarter and repaid $170 million of debt, resulting in pro forma net leverage today at 1.1x a very strong balance sheet that positions us well for further M&A. Before discussing segment performance, I wanted to remind everyone that our adjusted results exclude the benefit from [indiscernible] tariff recoveries recorded during the quarter.

Once again, in our view, it's important to isolate these onetime benefits from the true underlying operating trends in the business. A few more details on the segments of the quarter here. Starting with Aerospace and Advanced Technologies.

Sales of $344 million increased 27% in the quarter, with core sales up 9.5%. Our record backlog of nearly $1.3 billion increased 9% on a core basis and increased 20%, including the impact of the DRC acquisition. Once again, demand remains very strong across our highly diverse portfolio.

Top line strength in our core business was driven by the commercial OE ramp as well as ongoing broad-based strength within the defense market. Total aftermarket remained strong, bolstered by military and when isolating prior year initial provisioning was up 11%, with core commercial aftermarket up at a high single-digit rate, exactly what we expected.

Adjusted segment margin was exceptional at 26.3% ahead of our core leverage expectations and up 100 basis points year-over-year. That performance is notable given the higher OE sales and expected dilution from the drug acquisition and it speaks to the resiliency of our margin profile, irrespective of any changes in OE aftermarket mix.

Drug continued to outperform our expectations, and our core A&E business delivered another very strong quarter. Taken all together, we remain very confident in our full year segment sales outlook and continue to expect full year core sales growth slightly ahead of our 7% to 9% algorithm.

The diversity of the overall AAT portfolio supports the durability of that 7% to 9% regardless of periodic changes in the sales composition, whether that be in OE versus aftermarket or commercial versus military. Moving on to Process Flow Technologies.

In Q3, we delivered sales of $413 million, up 29% compared to a year ago with core sales up 6.2%, and the acquisitions of [ Panametrics ] were topotecan adding nearly 24 points of growth. Demand improved significantly in the quarter. Compared to the prior year, core FX-neutral backlog of PFT increased 8% on a sequential basis was up 2% and core FX-neutral orders were up 20% year-over-year and up 8% sequentially.

Adjusted operating margin was a record 24% and was 80 basis points above the prior year. And like AAT, results were above our expectations, given better performance across both our core businesses and each of our 3 acquired businesses. In summary, another outstanding quarter.

Moving to the nonoperational items below the segments. Corporate expense for the quarter was $20 million as expected. And for the full year, we expect to be within our previously guided $80 million to $85 million range.

Net nonoperating expense in the quarter was $14 million and we continue to estimate full year 2026 net nonoperating expense of approximately $58 million.

And lastly, we continue to estimate our tax rate for the year to approximate 23%. And taking all of this into account, our performance to date as well as the risks and opportunities we see ahead.

As Alex mentioned, we are raising our adjusted full year guidance by $0.35 to a range of $7.23 to $7.38. Overall, again, an outstanding year-to-date and momentum continues to build. And with that, operator, we are now ready to take the questions.

Operator

[Operator Instructions] And we'll take our first question from Jeff Sprague with Vertical Research.

質疑応答

Jeffrey Sprague

On TSI, Alex, obviously, very, very encouraging. Is the endpoint now much higher on this than you thought also, obviously, you're ahead of schedule on what you wanted to do. But as the upside were even bigger than you thought maybe you could kind of frame that relative to how you initially bridged the deal shortly after you closed it.

Jason Feldman

Yes. Thank you, Jeff. So yes, the upside is higher. I think we have that 5-year mark, where we're going to go from $60 million EBITDA to $150 million in 5 years. Now we think that's going to be quicker than that. And then when we look at the 5-year mark, the growth is going to be higher and the margins are going to be higher as well. So outside to that 5-year reference point for sure.

Jeffrey Sprague

And then one of the other sort of interesting things here, and I don't know if it's how you plan to approach all deals. But a lot of companies that are doing deals, right, seem to be allergic to trying to fix stuff.

They just want to pay for growth. Not saying that everything you'll be looking to buy is a fixer upward. But both PSI and Trillium, right? They seem to win good assets, maybe not run the way they should be an opportunity to kind of run it through your business system. As you look at the M&A pipeline, is there a lot of that sort of asset opportunity out there? .

Alejandro Alcala

Yes, Jeff. So every -- yes, that's a good observation. I think we do look at deals from the lens of CBS. So we obviously would see more opportunity than the seller.

But you feel is different. There's other deals. You may remember, Optech, which we also did earlier this year, a smaller deal we don't talk a lot about, but that was a high-growth business, very well run, and we're just adding contributing to it.

So I think we're open to a combination of circumstances, certainly not opposed to turnarounds or improvements like what we've been doing. It's all about where we see shareholder value creation and a combination of a path to improving the portfolio when we're hitting that 3-, 5-year mark.

Operator

We'll take our next question from Matt Summerville with D.A. Davidson.

Matt Summerville

I was wondering if you could maybe comment, you've sold the business up in Canada. You're in the process of selling the U.K. business -- are there more consequential portfolio actions still to be had specific to PFT?

And I'm also curious, sort of tangential to that, given that I would assume that transaction in isolation is going to be dilutive. Maybe comment on that and maybe how much Trillium can backfill relative to that dilution .

Alejandro Alcala

Yes. Thanks, Matt. So there is no more substantial divestitures that we're looking at right now. We evaluate the portfolio every year and our thinking could change.

But if you recall, like you mentioned, we divested that Crane Supply in Canada exposure to nonresidential construction. This business in BSU primary exposure is also nonresidential.

So this completes our exit of that market, a very well run business operated by a great team, but not really aligned to the markets that we're trying to expand into. As far as the accretion dilution, I'll let Rich answer that.

Richard Maue

Yes. Matt, yes, I think the way to think about the BSU business, right, we did -- this is a business that does roughly $160 million will be the outlook this year in revenue, and they're essentially at fleet margin.

So when you look at that and compare to Trillium, Trillium is $115 million in revenue with below fleet margin. So there will be some dilution to your point, obviously, the timing and the amount -- the timing of the close and the amount will coincide, right?

So we're currently thinking that, that will close sometime near the end of the first quarter. So if you tried to create a model around that, it's not a full year impact, but we would expect to offset a good portion of that with Trillium in the year. If that helps.

Matt Summerville

Perfect. And then maybe if you could just provide a little bit more end market and geographic color specific to in the context of that 20% year-on-year improvement you saw in organic order activity.

Alejandro Alcala

Yes, Matt. So it's looking quite positive from our perspective for PFT. I think a number of end markets that are seeing the growth, which is a positive from our perspective, makes us confidence on sustainability. .

We -- where we've seen the tailwind, those markets where we've been focused on over the last few years and increasing our exposure cryogenics, which is driven by space launch, water, wastewater, primarily U.S.-based business, where it's been resilient pharma, which our backlog is growing, and we expect increased investment in particular in the U.S. power as well.

So all these markets and of note, Chemical continues to be flat, where in the past, we've depended on chemical recovery to boost our growth -- that's not the case anymore in PST. So that chemical recovery is all upside still. We expect to drive growth without depending on that, and that will be additive to it.

I think regionally, U.S. continues to be the best market overall. Europe pretty flat. I think Middle East has recovered from the first half and continues to be solid, and then we have much less exposure in the rest of the world.

Operator

We'll take our next question from Nathan Jones with Stifel.

Nathan Jones

Maybe a follow up maybe a follow-up around the chemical market there. I would imagine it's probably the tale of a couple of different regions with capacity still coming out of Europe and maybe capacity improvements in the U.S. .

Maybe you could talk about chemical in a little bit more detail from a regional perspective and your outlook for a recovery there is -- I mean, if Europe just gets to being kind of a flat chemical market or something like that and stops going down, can the U.S. add growth to that, just how you view the shape of a recovery there?

Jason Feldman

Yes, Nathan. So Yes. I think you stated in Europe, we expect to continue to be flat even going to next year. I think the 2 markets that are the most interesting for us is the U.S. and Middle East. I think the U.S., as I mentioned in the last call, is held up pretty well.

As you know, when oil prices are high, there's a feedstock advantage on natural gas. So even when there's capacity globally, it makes sense for chemical companies to invest in the U.S. So we see some sporadic project activity.

Middle East also recovering. I think a full recovery that you'll notice in the P&L will come -- it's usually driven by construction, residential construction, durable goods, which I'm not expecting, not counting on at least in the first half of '27, we'll see after that.

But again, very pleased with the transformation of the portfolio that we're much less dependent on that recovery to drive growth.

Richard Maue

Maybe just to add, if you recall, our chemical exposure is mainly in the U.S., right? So maybe 70% of our chemical exposure is U.S.-based.

Nathan Jones

I'm going to try and pin you down a little bit more on PSI. The 5-year target was $150 million said you're going to get that quicker than that now. Do you have a new target for the 5-year number that's over that $150 million?

Alejandro Alcala

Yes. I mean I think -- it will grow in the 4% to 6% range and be leveraging that 35%, 40% after the 3-year mark.

Operator

We'll take our next question from Myles Walton with Wolfe Research.

Myles Walton

I'm curious if -- if I can on something off here, as were the acquisitions of PFT about 100 basis points dilutive to the reported margins, just backing into it based on -- you talked about up 500 basis points this year for the acquisitions. And then if that's the case, the 300 basis points of core margin expansion on 6% core growth, could you just maybe help us understand how you got that kind of operating leverage in the core business.

Richard Maue

Yes. I mean, in the quarter, look, it was -- I think you you're correct. Our performance from a margin point of view was exceptional. The leverage on the core business. And if I just -- I'll give both in the aerospace Advanced Technologies sector.

We were just above the high end of our 35% to 40%. So I think low 40s in terms of operating leverage there. And it's a combination of everything, right?

We just continue to execute really well from a price cost point of view, a productivity point of view and so forth, even in the face of any changes in mix. So like I said, the durability and resiliency of our Aerospace & Advanced Technologies part of the portfolio.

We're going to see that kind of performance irrespective of the composition of revenues. On the PFT side, we're already accretive in that zone today with the deals as we're exiting the year. Our core leverage in the quarter was just -- I think it was just north of 40%, something like that. So fairly solid.

Alejandro Alcala

Myles, just to add to that. We've continued to invest in PFT through the cycle. So there's no incremental cost increase that we'll see. So our leverage is pretty strong.

As we continue to mix more into these higher growth market. That's also where we are more profitable. So we see this bit of a flywheel effect where the growth is in our higher-margin businesses.

So the incremental leverage will be very solid in PST as we continue to drive growth.

Myles Walton

Got it. And just a clarification, if I could. The margin is up 500 basis points. That's for the full year. So you're saying you're already above that level here in the third and fourth quarter. Is that right? In terms of the PSI acquisition.

Richard Maue

Yes. In the second half of the -- yes, in the second half, just mathematically, I think we have to be there. .

Myles Walton

Yes, great. And then -- so then this PFT performance from a margin perspective, we should think about this as being reasonably sustainable at these levels?

Richard Maue

Yes. Yes. Again, it gets back to our core leverage rate in that 35% to 40% range through cycles. And we expect Q4 to be very, very similar. .

Operator

We'll take our next question from Dan DiCicco with BMO Capital Markets.

Daniel DiCicco

You mentioned PFT wins throughout the quarter. I think power, cryogenics wastewater. Could you provide some color on what you're seeing there?

Alejandro Alcala

Yes. If you think about those markets, Dan, cryogenic, the 2 main markets are space launch, on the rocket itself but on the launch pads and those build-outs continue.

So we're seeing good traction there. And then the second biggest market is just general aerospace in the factories with environmental testing to aerospace ramp-up continues. We see that demands and the teams are doing an exceptional job.

When you think about power again, our power business is mainly U.S.-based and the expansion on natural gas combined cycle turbines. That's where we see the momentum. And pharma -- similar in the U.S., the reshoring activity of funnels are increasing. So capacity expansion in the U.S., those type of project wins. Those are some highlights then. Always we expect to continue those markets to continue to '27.

Operator

And we'll take our next question from Ronald Epstein with Bank of America.

Unknown Analyst

This is Andrew Steiner on for Ron. I just wanted to ask a quick one on the missile demand and the broader domestic munitions ramp with several primes securing ops over the past few months.

Can you talk about how the process towards getting under contract for these programs has looked from your end so far?

Alejandro Alcala

Yes, I'll comment, and then I'll let Rich comment just we said, we're in about 15 missile programs. I think our jump-off point this year is around $35 million, mostly or different type of product power products and microwave products. And we expect next year to grow 40%, 50%.

A lot of that demand is already in the backlog. And then the projections for -- after that, 4 to 6x growth of the 35 base. And I think is where these contracts come into play, securing a bit more growth next year, but also securing that continued expansion growth through the rest of the decade. Do you have anything?

Richard Maue

I would just -- I would echo that, but just say that the demand signals that we're getting just continue to increase. We continue to see a lot of activity, a lot of RFQ work and so forth to the point that you made, we're seeing a lot of that. It's not slowed. It's increased.

Unknown Analyst

Can you just comment on what the process with these UPS actually looks like from the view of a subcontractor?

Alejandro Alcala

You broke up a little bit. Can you repeat?

Unknown Analyst

Yes. I was just looking to see if you guys could provide some color on what the UCA contracting process has looked like a view of a contract?

Alejandro Alcala

Yes, I think you asked -- I don't know if everybody heard, but we're seeing to break up how the contract processing looks for that missile demand. So we get RFP requests for tranches of multiyear opportunities for the different programs.

And we provide those updated quotes. And then we align with the customer to cure and then get a contract in a purchase order. So it's all happening at different times and different programs for different tranches for different periods of year that's on an ongoing basis. Hope that helps.

Operator

[Operator Instructions] I'd like to now announce Justin Ages with CJS Securities.

Justin Ages

Given the ongoing repositioning that you guys have done in PFT, can you give us an update on what the relative contribution of each of the end markets is you used to say like nuclear, 5%. Anything like that so we can see what the current contributions are?

Alejandro Alcala

Yes. I'll give you a quick snapshot. So I think starting with chemical, right? In the past, it's been like 30%. Now we have it close to 20% in chemical, water wastewater is around 15%; general industrial, up 20%.

And then our Power business, combined with -- when I say power, it's gas and nuclear -- it's like 15% with [indiscernible] I think those are the main ones of them.

Justin Ages

Great. And then given lingering conflict in the Middle East. Can you just remind us what your current exposure there is?

Alejandro Alcala

So exposure is mainly in PST and it's less than 5% overall. So what we -- we don't see really any material impact this year going forward. We saw some delays in shipments earlier in the year that's somewhat normalized. There's plenty of activity -- so not really a headwind that we expect.

Richard Maue

I'd say maybe tangentially, it's just the freight costs being higher and things like that, that we've been able to more than offset.

Operator

Thank you. This concludes the question-and-answer portion of today's call. I would like to now turn the call back to Alex Alcala for closing remarks.

Alejandro Alcala

Thank you for your questions and continued interest in Crane. We have significant momentum across the company, a record backlog and substantial opportunities ahead.

Most importantly, we have a proven team, a proven system. We remain highly confident in creating future and our ability to create long-term shareholder value. Thank you, and have a great day.

Operator

Thank you. This concludes today's Crane Company Third Quarter 2026 Earnings Conference Call. Please disconnect your lines at this time, and have a wonderful day.